Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -47.99% is 21% above its 2-year average of -60.83%, near the high end of its 2-year range (-113.29%–-41.27%).
As of the fiscal period ended Friday, July 31, 2026. 2.33% above its 12-month average of -49.13%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q1 FY2027 (2026-07-31): -47.99%.
RETURN ON INVESTED CAPITAL (ROIC)
-47.99%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-49.13%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+2.33%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.27%
median of 787 covered companies
CURRENT VS SECTOR MEDIAN
-36.05%
vs the sector median at left
Kestra Medical Technologies, Ltd.
Market Cap
$1.60B
Return on Invested Capital (ROIC)
-47.99%
TTM Avg
-49.13%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.61B
Return on Invested Capital (ROIC)
-50.20%
TTM Avg
-38.39%
3Y Avg
-45.36%
5Y Avg
-41.83%
Market Cap
$1.59B
Return on Invested Capital (ROIC)
2.43%
TTM Avg
0.22%
3Y Avg
-0.18%
5Y Avg
1.11%
Market Cap
$1.62B
Return on Invested Capital (ROIC)
9.26%
TTM Avg
2.84%
3Y Avg
1.55%
5Y Avg
-0.61%
Market Cap
$1.63B
Return on Invested Capital (ROIC)
-8.93%
TTM Avg
-17.04%
3Y Avg
-10.88%
5Y Avg
-10.88%
Market Cap
$1.64B
Return on Invested Capital (ROIC)
-7.32%
TTM Avg
-17.29%
3Y Avg
-24.58%
5Y Avg
-25.54%
Market Cap
$1.54B
Return on Invested Capital (ROIC)
8.36%
TTM Avg
8.44%
3Y Avg
9.74%
5Y Avg
16.58%
Market Cap
$1.54B
Return on Invested Capital (ROIC)
-32.15%
TTM Avg
-60.15%
3Y Avg
-48.54%
5Y Avg
-35.53%
Market Cap
$1.53B
Return on Invested Capital (ROIC)
-63.12%
TTM Avg
-24.75%
3Y Avg
-38.52%
5Y Avg
-35.23%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kestra Medical Technologies, Ltd. (KMTS) | $1.60B | -47.99% | -49.13% | N/A | N/A |
| Ocular Therapeutix, Inc. (OCUL)vs › | $1.61B | -50.20% | -38.39% | -45.36% | -41.83% |
| Omnicell, Inc. (OMCL)vs › | $1.59B | 2.43% | 0.22% | -0.18% | 1.11% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.62B | 9.26% | 2.84% | 1.55% | -0.61% |
| Septerna Inc (SEPN)vs › | $1.63B | -8.93% | -17.04% | -10.88% | -10.88% |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.64B | -7.32% | -17.29% | -24.58% | -25.54% |
| Innoviva, Inc. (INVA)vs › | $1.54B | 8.36% | 8.44% | 9.74% | 16.58% |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.54B | -32.15% | -60.15% | -48.54% | -35.53% |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.53B | -63.12% | -24.75% | -38.52% | -35.23% |
| Nutex Health, Inc. (NUTX)vs › | $1.53B | 33.76% | 23.76% | -16.29% | 5.45% |
ROIC
-48.0%
ROE
-67.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-07-31 | -47.99% |
| 2026-04-30 | -43.73% |
| 2026-01-31 | -42.69% |
| 2025-10-31 | -61.35% |
| 2025-07-31 | -49.91% |
| 2025-04-30 | -41.27% |
| 2025-01-31 | -113.29% |
| 2024-10-31 | -86.37% |
